News Daily News ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients Michael O'Riordan March 26, 2025
News Daily News Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT Caitlin E. Cox December 27, 2024
News Conference News TCT 2024 ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients Todd Neale October 30, 2024
News Conference News TCT 2023 BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years Caitlin E. Cox October 27, 2023
News Daily News Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel L.A. McKeown August 23, 2023
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Conference News AHA 2022 ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD Shelley Wood November 06, 2022
News Daily News Hospital Culture, Physician Preference Mostly Drive IVUS/OCT in PCI L.A. McKeown October 24, 2022
News Conference News ACC 2022 Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD L.A. McKeown April 04, 2022
News Conference News AHA 2021 No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis Michael O'Riordan November 15, 2021
News Conference News CRT 2021 BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients Caitlin E. Cox March 16, 2021
News Daily News Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5 Todd Neale October 09, 2020
News Daily News PCI for Left Main CAD: Meta-analysis Finds No Increased Risk of Mortality Michael O'Riordan June 12, 2020
News Daily News New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD Michael O'Riordan June 01, 2020
News Conference News ESC 2019 BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI Caitlin E. Cox September 10, 2019
News Daily News A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex L.A. McKeown March 01, 2019